0 items USD 0.00Search
Your search for "global markets direct rett syndrome pipeline review h1 2017" gave back 239 results.
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
Catalog:
IQ4I
February 2017
Price: USD 3,600.00
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals For a long time, messenger RNA (mRNA)...
Catalog:
La Merie Publishing
June 2017
Price: USD 2,520.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Dandy-Walker Syndrome Treatment market will undergo major...
Catalog:
Arsta
October 2022
Price: USD 3,600.00
Important bispecific antibody targets are basically in clinical practice, and many momentous bispecific antibodies will be born in the future. The...
Catalog:
AEI
June 2021
Price: USD 3,000.00
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the...
Catalog:
La Merie Publishing
February 2015
Price: USD 390.00
FDA has recently approved much-awaited first dedicated coronary bifurcated stent for treatment of cardiovascular diseases. The report “Global...
Catalog:
Rockville Research
August 2018
Price: USD 1,500.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „ Antibody-Drug Conjugate Pipeline...
Catalog:
La Merie Publishing
December 2016
Price: USD 880.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The report...
Catalog:
IQ4I
December 2018
Price: USD 3,600.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research’s latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
“Pancreatic Beta-cell Protection Hot Targets & Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the...
Catalog:
IQ4I
August 2016
Price: USD 3,600.00
Vectorized Antibodies for In Vivo Expression by DNA and mRNA report provides you with a landscape description and analysis of direct in vivo delivery...
Catalog:
La Merie Publishing
July 2021
Price: USD 2,550.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
Catalog:
La Merie Publishing
November 2016
Price: USD 225.00
